Nobel Biocare Holding AG (2.5%) (XSWX:NOBN) (NOBN SW - $17.75 - SIX Swiss Exchange), based in Zurich, Switzerland, is a manufacturer of premium dental implants and related equipment. On July 29, 2014, Nobel Biocare confirmed that it was in preliminary discussions with third parties that had expressed interest in acquiring the company. On September 15, 2014, an official deal was disclosed with Washington, D.C. based Danaher, a leading industrial company with exposure to the medical device industry. Nobel Biocare shareholders will receive 17.10 Swiss Francs for each of their shares in a tender offer, which is expected to close on November 14. The transaction is expected to close by the end of 2014 pending regulatory approval in the U.S. and Switzerland.
From Mario Gabelli (Trades, Portfolio)’s ABC Fund Q3 2014 Commentary.
